Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

The Cooper Companies to Participate in the Wells Fargo Securities Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  The Cooper Companies, Inc.

Akers Biosciences Announces Q2 and H1 2018 Earnings

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  Akers Biosciences, Inc.

Cytori Reports Q2 2018 Business and Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  Cytori Therapeutics, Inc.

Mersana Therapeutics Announces Second Quarter 2018 Financial Results and Provides Business Updates

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  Mersana Therapeutics, Inc.

Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  STRONGBRIDGE BIOPHARMA PLC

Mateon Therapeutics Reports Second Quarter 2018 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  MATEON THERAPEUTICS, INC.

Atrion Corporation Increases Quarterly Cash Dividend by 13%

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  Atrion Corporation

VistaGen Therapeutics Reports Fiscal 2019 First Quarter Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  VistaGen Therapeutics, Inc.

Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  Organovo Holdings, Inc.

ContraFect to Participate in FDA Workshop on Development of Non-Traditional Therapies for Bacterial Infections

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  Contrafect Corporation

Milestone Scientific Provides Business Update for the Second Quarter of 2018

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018

Vigil Reports Increased Revenue and Earnings in First Quarter

Read more ››
By: Nasdaq / GlobenewsWire - 14 Aug 2018
Related companies:  Vigil Health Solutions Inc.

Infertility Treatment Market Clinical Aspects, Reviews and Analysis 2018 to 2022

PUNE, India, August 14, 2018 /PRNewswire-iReach/ -- The Global Infertility Treatment Market is projected to display a robust growth represented by a CAGR of 8.25% during 2018 - 2022.

Read more ››
By: PR Newswire Association LLC. - 14 Aug 2018

Actinium to Provide Update on Pivotal Phase 3 SIERRA Trial Following Positive Data Monitoring Committee Meeting

NEW YORK, Aug. 14, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or "the Company"), today announced that it will conduct a conference call on Wednesday, August 15, 2018 at 9:00 AM ET to provide an update on the Pivotal Phase 3 SIERRA Trial (Study... Read more ››

By: PR Newswire Association LLC. - 14 Aug 2018
Related companies:  Actinium Pharmaceuticals, Inc.

Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

SAN DIEGO and VANCOUVER, British Columbia, Aug. 14, 2018 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late stage clinical trials for the treatment of patients... Read more ››

By: PR Newswire Association LLC. - 14 Aug 2018
Related companies:  Sophiris Bio Inc.

Biocept Reports Second Quarter 2018 Financial Results

SAN DIEGO, Aug. 14, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports... Read more ››

By: PR Newswire Association LLC. - 14 Aug 2018
Related companies:  Biocept Inc.

Cumberland Pharmaceuticals Reports Second Quarter 2018 Financial Results

NASHVILLE, Tenn., Aug. 14, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced second quarter 2018 financial results and Company update.... Read more ››

By: PR Newswire Association LLC. - 14 Aug 2018
Related companies:  Cumberland Pharmaceuticals Inc.

INVO Bioscience Reports Record Second Quarter 2018 Financial Results

MEDFORD, Mass., Aug. 14, 2018 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell(TM), today announced its Q2 2018 financial results for the quarter ended June 30, 2018 and recent highlights.

... Read more ››
By: PR Newswire Association LLC. - 14 Aug 2018

Biohaven Pharmaceuticals Reports Second Quarter 2018 Financial And Recent Business Results

NEW HAVEN, Conn., Aug. 14, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders, today reported financial... Read more ››

By: PR Newswire Association LLC. - 14 Aug 2018
Related companies:  Biohaven Pharmaceutical Holding Company Ltd

Global Electrophoresis Systems Market 2018-2022 - Key Vendors are Agilent Technologies, Bio-Rad Laboratories, General Electric, Lonza, Merck KGaA & Thermo Fisher Scientific

DUBLIN, Aug. 14, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Aug 2018
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑